A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients

• Published in: Pain (Amsterdam) Vol. 93; no. 2; pp. 185 - 190
• Main Authors: Lines, Christopher R, Vandormael, Kristel, Malbecq, William
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 01.08.2001; Lippincott Williams & Wilkins, Inc; Elsevier
• Subjects: Adolescent; Adult; Aged; Biological and medical sciences; Double-Blind Method; Female; Fundamental and applied biological sciences. Psychology; Humans; Illness and personality; Illness, stress and coping; Male; Middle Aged; Migraine; Migraine Disorders - diagnosis; Migraine Disorders - drug therapy; Pain Measurement; Psychology and medicine; Psychology. Psychoanalysis. Psychiatry; Psychology. Psychophysiology; Rizatriptan; Serotonin Agents - administration & dosage; Sumatriptan; Sumatriptan - administration & dosage; Treatment Outcome; Triazoles - administration & dosage; Tryptamines; Vasoconstrictor Agents - administration & dosage; Visual analog scale; Visual analog scale; Rizatriptan; Sumatriptan; Migraine; Human; Headache; Nervous system diseases; Evaluation scale; Cardiovascular disease; Cerebral disorder; Vascular disease; Pain; Treatment; Central nervous system disease; Clinical trial; Neurological disorder; Cerebrovascular disease

A visual analog scale (VAS) method of assessing headache pain was compared with a standard categorical four-grade scale (4GS) in a randomized, placebo-controlled, double-blind, clinical trial involving 792 treated migraine outpatients who received oral rizatriptan 5 mg, sumatriptan 50 mg, or placebo...